Bad forecast – There will be a “significant drop” in the effectiveness of the current vaccine against Omicron, and it will take several months to develop a new one, the head of Moderna told the Financial Times in an interview.
Audrey LE GUELLEC –
“Every scientist I’ve spoken to says, ‘This is not going to happen.’ In an interview Financial Times, The head of Moderna Pharmaceutical Laboratory on Tuesday expressed pessimism about the effectiveness of existing vaccines against the omigran variant of the corona virus.
All information about
Govit-19: The challenge of the vaccine
There will be one “Significant Fall” Efficacy of current vaccines against Omigran, Stephen Bonsell evaluates It is not yet possible to calculate it due to the lack of more accurate data from the British newspaper, which will be available in the next two weeks.
New vaccine to fight Omigran
“I like to think, but I have to be careful, the vaccine that is made of it is at least somewhat protective (…) I know nothing”, For his part, was evaluated at the LCI this Monday by Alain Fischer, chairman of the steering committee for the Covit-19 anti-vaccine strategy.
“Worse or worse, there will be the option of developing new vaccines that no longer use the spike protein of the ‘Wuhan virus’, but replace it with the spike of the Omigron virus.”, Continued believing that “It can go very fast”.
Stephen Bonsell wanted more detail on establishing the large-scale production of this new vaccine. “Several months”.
- New versions of the vaccine are already under development to cope with the Omigron variant
- Covid: Now the obligation to modify vaccines in agreements between the EU and laboratories
Various manufacturers, including Moderna, AstraZeneca, Pfizer / BioNTech and Novavax, have announced that they are actually starting to work on this hypothesis, saying they believe in their ability to fight Omicron by developing a new vaccine. Russia has announced in its “Sputnik V” version that it is specifically targeting Omigron. “Impossible Case” The current serum may not be sufficient. If so, the country will be ready “Deliver hundreds of millions of booster doses to the international market against the Omicron variant by February 20”, Said the Russian Sovereign Fund.
“If it is necessary to replace existing vaccines, we can approve them within three to four months.” Manufacturers from the moment “Begin to change” Emer Cook, director of the European Pharmaceuticals Agency (EMA), told the European Parliamentary Committee. He said other bodies would have to decide whether it was necessary to inject further.
“It’s better to start this process by stopping if you do not need to”, “ On Monday Professor Alain Fischer evaluated, recalling that these companies have already gone this route. “For previous delta and gamma types” Most “No need to go too far, much better”.
In the same case
Most read articles
Live – Govt-19: The limit of 10,000 patients admitted to the hospital has been exceeded
Josephine Baker: When an (almost) empty coffin enters the Pantheon
PARIS: A teacher from Lycee Montaine was violently assaulted in class by a student.
Live – Marine Le Pen judges Eric Zemor’s nomination clip as “looking back and twilight”
Omigron Variation: Why does the WHO call for no closure of borders?
Protects the purpose of information
Verified And thanks to the revenue is accessible to everyone
To help us maintain this free service you can “change your choice” and accept all cookies.
Modify and accept everything
“Tv expert. Writer. Extreme gamer. Subtly charming web specialist. Student. Evil coffee buff.”